Dilip Bhat looks at pharma to find the next multibagger

Posted on:
Key Points

From midcaps, some of the stocks that we like have really run up quite a bit, but within this space, Radiant Cash Management looks pretty interesting..

Dilip Bhat, Market Expert, says one frontline name that stands out is Divi's Laboratories..

Europe has capitulated in terms of the production and the way the opportunities are flowing to Indians; we all talk about China plus, but before China plus one happened, Europe has thrown good opportunities the India way and that is where Divis is going great guns..

It is a frontline, good liquidity stock and in the next couple of quarters or even next couple of years, we will see a number of new molecules have come Divis way and the kind of capacity that they have can surprise everyone on the positive side..

What really stands out is that the opportunity is huge though the perception about the cash as a business is nothing really great, that the way the UPI is happening, they feel that the cash business may not be all that good but Radiant Cash Management can clock 18% to 20% growth for the next couple of years and the valuations are very cheap...

You might be interested in

Technical Breakout Stocks: How to trade Hero MotoCorp, JBM Auto and Star Cement on Tuesday

12, Feb, 24

The S&P BSE Sensex fell more than 500 points while the Nifty50 managed to hold on to 21,600 levels. Sectorally, buying was seen in healthcare and IT stocks while public sector, utilities, telecom and realty stocks saw some selling pressure.